In the news Opinion: New painkillers critical to fight opioid epidemic, broader pain crisis in BioSpace Tris’ next-gen pain drug completes trio of clinical wins, setting up push to FDA in Fierce Biotech Cebranopadol shows lower abuse potential compared to existing pain therapies in Drug Topics Tris looks to take on opioids with latest cebranopadol data in Citeline Tris Pharma’s alternative to opioids reduces post-surgery pain in phase 3 trial ahead of NDA submission in Fierce Biotech Tris Pharma awarded up to $16.6M to advance treatment for opioid use disorder in New Jersey Business Magazine
